Search Results

1 - 10 of 418 items :

Clear All

References 1. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain . J Clin Endocrinol Metab 85: 2434-2438, 2000. 2. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study . J Clin Endocrinol Metab 83: 3078-3082, 1998. 3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES

References 1. Rotterdam ESHRE / ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome. Fertil. Steril. 2004; 81 (1): 19-25. 2. National Institutes of Health Evidence-based methodology workshop on polycystic ovary syndrome, December 3-5, 2012. Executive summary. https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf . 3. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome

References 1. Young RH, Shully RE. Steroid cell tumors of the ovary. In: Fox H, Wells M, editor. Obstetric & Gynecological Pathology. Spain, Churchill Livingstone, 2003. pp. 845-56. 2. Hayes MC, Scully RE. Ovarian steroid cell tumors [not otherwise specified]: a clinicopathological analysis of 63 cases.Am J Surg Pathol. 1987;11:835-45. 3. Scully RE, Young RH, Clement PB. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament.Washington, DC: Armed Forces Institute of Pathology. Steroid cell tumors, 1996: pp. 227-38. 4. Ferriman D, Gallwey JD

References 1. Gurunath S, Pandian Z, Anderson RA et al. Defining infertility--a systematic review of prevalence studies. Hum Reprod Update. 2011; 17(5): 575-588. 2. Łepecka-Klusek C, Pilewska-Kozak AB, Jakiel G. Infertility - a disease or not according to the WHO definition. Med Og Nauk Zdr. 2012; 18(2): 163-166. 3. Shannon M, Wang Y. Polycystic Ovary Syndrome: A common but often unrecognized condition. J Midwifery Women’s Health. 2012; 57(3): 221-230. 4. Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women’s health aspects of

References 1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al . A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84: 4006-4011, 1999. 2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO . The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89: 2745-2749, 2004. 3. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ . The prevalence of polycystic ovary syndrome in a community sample assessed

References 1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89: 2745-2749, 2004. 2. Asuncion M, Calvo RM, San Millan JL et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85: 2434-2438, 2000. 3. Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and

REFERENCES 1. Dutta S, Burks DM, Pepling ME: Arrest at the diplotene stage of meiotic prophase I is delayed by progesterone but is not required for primordial follicle formation in mice. Reproductive biology and Endocrinology 2016, 14(1): 82. 2. Song K, Ma W, Huang C, Ding J, Cui D, Zhang M: Expression Pattern of Mouse Vasa Homologue (MVH) in the Ovaries of C57BL/6 Female Mice. Medical science monitor. International Medical Journal of Experimental and Clinical Research 2016, 22: 2656-2663. 3. Kerr JB, Myers M, Anderson RA: The dynamics of the primordial follicle

References Al-Eisa E, Gabr SA, Alghadir AH. Effects of supervised aerobic training on the levels of anti-Mullerian hormone and adiposity measures in women with normo-ovulatory and polycystic ovary syndrome. J Pak Med Assoc 67, 499-507, 2017. Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19, 471-482, 2005. Artimani T, Karimi J, Mehdizadeh M, Yavangi M, Khanlarzadeh E, Ghorbani M, Asadi S, Kheiripour N. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory

References 1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005; 352:1223-36. 2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19:41-7. 3. Cheung AP. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol. 2001; 98:325-31. 4. Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006; 20:235-44. 10.1016/j.beem.2006.03.005 5. Iatrakis G

References 1. Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. European Journal of Endocrinology 2014; 4 1-29. DOI: 10.1530/EJE-14-0253 2. Wang R, Mol BW. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? Hum Reprod. 2017 Feb; 32(2):261-4. DOI: 10.1093/humrep/dew287 3. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the Polycystic Ovary Syndrome. Int J Obes Relat Metab